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ABSTRACT 
 
Studies have indicated that approximately 30% of people with heart disease experience 
major depressive disorder (MDD). Despite strong clinical evidence of a link between the two 
diseases, the neurobiological processes involved in the relationship are poorly understood. A 
growing number of studies are revealing similar neuroanatomical and neurochemical 
abnormalities resulting from both depression and heart disease. The locus coeruleus (LC) is a 
group of neurons in the pons that synthesize and release norepinephrine, and that is known to 
play a significant role in depression pathobiology. For example, there is evidence that tyrosine 
hydroxylase (TH) is elevated in the LC in depression. In addition, there is evidence that the LC 
plays a role in cardiovascular autonomic regulation. The hippocampus is another region that 
exhibits abnormalities in both depression and heart disease. In this study, the levels of TH in the 
hippocampus and LC were examined in the guinea pig pressure-overload model of heart disease. 
TH levels were also measured in the pressure-overload model treated with vagal nerve 
stimulation, a new investigational therapeutic intervention in heart disease.  This study found that 
there were no changes in TH levels in the LC or the hippocampus of the pressure-overload model 
or in the pressure-overload model treated with vagal nerve stimulation.  
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1. INTRODUCTION 
Cardiovascular disease (CVD) and major depressive disorder (MDD) are two of the most 
prominent diseases in our healthcare system today. CVD is the leading cause of death in the 
United States, killing an estimated 610,000 people annually (CDC, NCHS, 2015). The National 
Institute of Health reports that 6.7% of Americans suffer from depression (Kessler et al., 2005). 
While the two diseases can appear as separate entities, they are known to be clinically linked. 
Approximately 30% of people with heart disease develop symptoms of depression (Lesperance 
and Frasure-Smith, 2000). Also, people with depression are more likely to develop CVD (Hare, 
Toukhsati, Johansson, and Jaarsma, 2014). Unfortunately, depressed patients with heart disease 
typically experience more adverse events, such as an increase in symptoms, poorer responses to 
medication, a slower rehabilitation, and ultimately a poorer quality of life. Depression also 
increases the probability of additional cardiac complications, as well as increases the mortality 
rate (Nair, Farmer, Gongora, and Dehmer, 2012; Parissis et al., 2007). There is also evidence of a 
correlational relationship, with the mortality rate and number of cardiac complications increasing 
with the severity of the depression (Hare et al., 2014). Despite the many associations between the 
two diseases, the underlying biological relationship is very poorly understood.  
The locus coeruleus (LC), a group of neurons located in the pons, is an area of interest in 
the neurobiological link between CVD and MDD.  It is the primary source of the 
neurotransmitter norepinephrine in the brain and plays a role in many physiological responses, 
including numerous behaviors.  Tyrosine hydroxylase (TH), an enzyme found in the LC, is the 
rate-limiting enzyme in the biosynthesis of norepinephrine. Studies have shown the relevancy of 
the LC in the pathophysiology of depression. The expression level of TH in the LC in brain 
tissue from depressed humans was shown to be significantly higher than that of age-matched 
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sudden-death control cases (Ordway, Smith, and Haycock, 1994; Zhu, Klimek, Dilley, Haycock, 
Stockmeier, Overholser, Meltzer, and Ordway, 1999). Research has also found that the LC plays 
a role in central control of the cardiovascular system by being connected to many cardiovascular 
regulatory centers. For example, nitrergic stimulation in the LC was shown to modulate heart 
rate and blood pressure (Yao, Finkelstein, and Lawrence, 1999).    
The hippocampus, known to play a vital role in learning and memory, is an additional 
brain area known to present pathology in depression, while likewise being impacted 
pathologically by heart disease. In regards to CVD, research has shown that the release of 
proinflammatory cytokines that occurs in CVD deleteriously affects the limbic system, 
particularly of the hippocampus (Liu et al., 2013). Apoptosis has been shown to occur in the 
hippocampus following experimentally-induced myocardial infarction in rats (Wann et al., 2007; 
Kaloustian et al. 2008). In the pathology of depression, atrophy in the hippocampus is associated 
with MDD, with recurrent depression being associated with a greater loss of hippocampal 
volume (Sapolsky, 2001).   
Another interesting similarity between CVD and MDD involves a treatment known as 
vagal nerve stimulation (VNS). VNS is administered through a pulse generating device that is 
surgically implanted into the chest and connected to the left vagus nerve. Initially used for 
epilepsy, VNS is now approved for use in patients with treatment-resistant depression. Research 
has shown marked improvement in patients with treatment-resistant MDD treated with VNS, 
despite the mechanism not being fully understood (Schlaepfer et al., 2008). More recently, VNS 
has gained great interest as a potential treatment to alleviate cardiac pathology following a 
myocardial infarction. VNS was shown to significantly increase the long-term survival after 
chronic heart failure in a rat model (Li et al, 2004). More recently, VNS was evaluated in 
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patients with chronic heart failure, and showed some promising results (Premchand, 2014). 
While many of the underlying mechanisms of VNS are unknown, its role as a potentially 
effective treatment in both MDD and CVD make it a point of interest. 
 
2. METHODS 
 
2.1 Pressure-Overload and Vagal Nerve Stimulation 
 Guinea pigs were utilized in this study (n=18). The guinea pigs were randomly assigned 
to one of three treatment groups: 1) sham control group (CO), 2) pressure-overload group (PO), 
and 3) pressure-overload in combination with vagal nerve stimulation group (PO + VNS). The 
pressure-overload in the PO and PO + VNS group was produced by a 15-20% chronic aortic 
constriction.  For the PO + VNS group, a vagal nerve stimulation device was implanted in the 
guinea pigs two weeks prior to the surgery to produce pressure-overload. The device was 
attached to the right cervical vagus nerve and delivered stimulation (20 Hz, 0.1 mA) in a 
continuous cycle of 14 seconds on and 48 seconds off. The guinea pigs were maintained for 60 
days post-PO. The PO + VNS group received stimulation during the 60 days. The sham controls 
were also maintained for the same length of time. The animals were then terminated, and the 
target brain tissues were dissected and stored at 80°C. This protocol was approved by East 
Tennessee State University’s IACUC.  
2.2 Collection of Locus Coeruleus and Hippocampal Tissue 
 Tissue from the LC was collected from the brainstem, using a micro-punch (2-mm 
diameter).  Hippocampal tissue was collected from a 50 um thick section of the temporal lobe, 
using a micro-punch (3.5-mm diameter). The collected tissue was stored at 80°C.   
2.3 Measuring Tyrosine Hydroxylase Immunoreactivity 
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 Protein from the micropunched LC and hippocampal tissue was isolated, solubilized, and 
separated by 4-10% polyacrylamide gel electrophoresis. The separated proteins were transferred 
to PVDF membranes and treated with polyclonal primary antibody generated against rabbit TH.  
The membrane was then exposed to horseradish peroxidase linked secondary antibody.  The TH-
immunoreactivity (ir) was then quantified and normalized to actin-ir by chemiluminescence 
using a G-box imaging system. 
2.4 Statistical Analysis 
 TH-ir levels were analyzed for each group (CO, PO, PO+VNS) for the LC and 
hippocampal tissue.  Statistical analysis was completed using a one-way analysis of variance 
(ANOVA) with a p-value set at 0.05 to determine statistical significance. 
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3. RESULTS 
 
3.1 Locus Coeruleus  
 The LC is the primary site for the synthesis of norepinephrine in the brain. This synthesis 
is dependent upon the levels of TH; the rate-limiting enzyme. Levels of TH in the LC tissue were 
measured to determine whether there were any changes induced in the PO group or in the PO 
group receiving VNS.  No significant changes were found between the TH levels of the sham 
controls and the PO group.  In addition, TH levels from the PO group that received VNS did not 
exhibit a significant difference from the sham controls or from the PO group. These results are 
expressed in Figure 1.  
Locus Coeruleus 
 
 
 
 
 
 
 
Treatment Group 
 Figure 1: Measurement of Tyrosine Hydroxylase Immunoreactivity in the LC. TH-ir      
normalized by actin-ir was examined in control (CO; open circles), pressure-
overload (PO; closed circles), and pressure-overload with VNS (PO+VNS; closed 
triangles) groups in micropunched tissue samples collected from the LC and 
hippocampus. 
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3.2 Hippocampus 
 Noradrenergic neurons of the LC project to the hippocampus where they synthesize and 
release norepinephrine. Levels of TH-ir were measured in hippocampal tissue from the three 
groups of animals to determine whether any changes were induced by PO or by PO plus VNS. 
No significant changes in TH-ir levels were observed between the sham controls and the PO 
group.  In addition, no significant changes in the levels of TH-ir were observed in the PO group 
that also received vagal nerve stimulation.  These results are expressed in Figure 2. 
Hippocampus 
 
 
 
 
 
 
 
 
 
 
 
Treatment Group 
Figure 1: Measurement of Tyrosine Hydroxylase Immunoreactivity in the 
Hippocampus. TH-ir normalized by actin-ir was examined in control (CO; open 
circles), pressure-overload (PO; closed circles), and pressure-overload with VNS 
(PO+VNS; closed triangles) groups in micropunched tissue samples collected 
from the LC and hippocampus. 
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4. DISCUSSION 
 The results from this study suggest that the PO guinea pig model does not significantly 
impact LC or hippocampal biochemistry at the level of the enzyme TH. Additionally, the results 
from the PO model combined with VNS imply that this treatment does not significantly 
influence the levels of TH in the LC or hippocampus. Despite a lack of significant differences in 
TH-ir, a positive trend was observed between the controls and the PO model. A positive trend 
was also observed between the controls and the PO model receiving VNS. Due to the small 
sample size, it is possible that a significant difference went undetected. By increasing the sample 
size, it would have allowed for a better statistical analysis between the groups. It is noteworthy 
that elevation in the activity of the LC is typically paralleled by an increase in the expression of 
TH protein, since increased activity translates to increased norepinephrine release requiring 
greater synthetic capacity for norepinephrine (Zhu, Klimek, Dilley, Haycock, Stockmeier, 
Overholser, Meltzer, and Ordway, 1999). Therefore, the present findings suggest that the PO 
model used did not significantly increase the activity of the LC. Likewise, at least in PO animals, 
VNS did not appear to change the activity of the LC. 
 This study indicated that the PO produced no effect on TH-ir. However, the lack of 
significant effects may have resulted from the modesty of the PO model with respect to the 
severity of heart failure. It has been shown that damage to the hippocampus occurs in rats during 
myocardial infarctions (Kaloustian et al. 2008). In this study, the PO was created by a 15-20% 
chronic aortic constriction. A higher amount of chronic aortic constriction, simulating a more 
severe condition, may have influenced brain pathology.  
TYROSINE HYDROXYLASE IN PRESSURE-OVERLOAD MODEL              10 
 People with CVD have an increased probability of developing MDD. Depression 
significantly increases the morbidity and mortality in individuals with CVD, making continued 
research in this area a significant need.      
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